Prognostic Models in Hepatocellular Carcinoma (HCC) and Statistical Methodologies Behind Them

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|15|1527-1532

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.15, 2007-05, pp. : 1527-1532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model

By  

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3485-3493

Blackwell Publishing

Access to resources Recommend Favorite

Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC) – an investigation in a department of surgical medicine

By Farker Katrin   Schotte Uwe   Scheele Johannes   Hoffmann Annemarie  

Experimental and Toxicologic Pathology, Vol. 54, Iss. 5-6, 2003-05 ,pp. : 387-391

Urban & Fischer

Access to resources Recommend Favorite

The Inducible Effect of LBP on Maturation of Dendritic Cells and the Related Immune Signaling Pathways in Hepatocellular Carcinoma (HCC)

By  

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 414-420

Bentham Science Publishers

Access to resources Recommend Favorite

Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)

By  

Current Cancer Drug Targets, Vol. 15, Iss. 5, 2015-01 ,pp. : 435-444

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma

By Lin Chih-Lin   Kao Jia-Horng  

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 441-443

Future Medicine

Access to resources Recommend Favorite